NKTR-174

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNKTR-174
Drug Alias Namedual receptor agonist/antagonist (Nektar)NKTR-174
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsMu opioid receptor agonists
TargetsGlutamate [NMDA] receptorMu opioid receptor
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNektar Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNektar Therapeutics
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A